Opioid Painkillers and Xanax or Valium a Deadly Mix: Study
WEDNESDAY, March 15, 2017 -- Mixing opioid painkillers with common anxiety and sleep medications is a prescription for a deadly overdose, a new U.S. study shows.
Of all fatal overdoses from narcotic medications, nearly 30 percent also involved... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 15, 2017 Category: Journals (General) Source Type: news
This Prescription Drug Is Implicated In Almost A Third Of All Opioid Overdose Deaths
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - March 15, 2017 Category: Consumer Health News Source Type: news
Opioid Painkillers and Xanax or Valium a Deadly Mix: Study
30 percent of fatal opioid overdoses involved both types of meds, but number of people prescribed both has spiked (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - March 14, 2017 Category: Psychiatry Authors: webmaster at doctorslounge.com Tags: Family Medicine, Neurology, Pharmacy, Psychiatry, News, Source Type: news
Most Popular NEJM Group Feature This Week: Diazepam Not Helpful for Back Pain (FREE)
By the Editors
Here ' s the most clicked-on item we featured … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 3, 2017 Category: Primary Care Source Type: news
Valium May Be Useless for Acute Lower Back Pain
Title: Valium May Be Useless for Acute Lower Back PainCategory: Health NewsCreated: 2/27/2017 12:00:00 AMLast Editorial Review: 2/28/2017 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - February 28, 2017 Category: Anesthesiology Source Type: news
Valium May Be Useless for Acute Lower Back Pain
Another study casts doubt on notion that potent painkillers can really help
Source: HealthDay
Related MedlinePlus Pages: Back Pain, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 28, 2017 Category: Consumer Health News Source Type: news
Valium May Be Useless for Acute Lower Back Pain
MONDAY, Feb. 27, 2017 -- For decades, emergency room staff often gave Valium to patients for an acute bout of bad lower back pain.
But a new head-to-head trial in an ER environment casts doubt on the notion that Valium or potent painkillers can... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 27, 2017 Category: Journals (General) Source Type: news
Your NEJM Group Today: Chlamydia Screening, Diazepam Not Helpful for Back Pain, Connecticut IM Opportunity (FREE)
By the Editors
Check out the latest offerings from NEJM Group:NEJM Clinical Practice Center: Chlamydial infection may result in pelvic inflammatory disease, … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 26, 2017 Category: Primary Care Source Type: news
Did the nerve agent VX kill Kim Jong Nam?
Last night Malaysian authorities announced that they identified the nerve agent VX taken off the face of Kim Jong Nam, who was murdered on February 13 at Kuala Lumpur International Airport.
As the History Channel video above indicates, nerve agents are potent acetylcholinesterase inhibitors that utilize the same mechanism as organophosphate insecticides such as parathion. Conceptually, the effect of VX exposure is simple: wherever in the body acetylcholine acts as a neurotransmitter, nerve agents cause unregulated, chaotic activity. There are generally 3 such sites:
muscarinic sites: connections between nerves and secr...
Source: The Poison Review - February 24, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical assassination Kim Jong Nam Kuala Lumpur International Airport malaysia murder nerve agent North Korea VX Source Type: news
Placebo and valium are equally effective for acute lower back pain in the ER
(American College of Emergency Physicians) Emergency patients treated with naproxen and placebo had outcomes as good as or better than patients treated with naproxen and diazepam (trade name Valium) for acute lower back pain, according to the results of a double-blind, randomized clinical trial published last week in Annals of Emergency Medicine ('Diazepam Is No Better Than Placebo When Added to Naproxen for Acute Low Back Pain'). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 16, 2017 Category: Global & Universal Source Type: news
Diazepam Intensol (Diazepam Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 17, 2017 Category: Drugs & Pharmacology Source Type: news
Neurelis closes Series B for intranasal diazepam spray
Neurelis, Inc. said today that it closed a Series B financing round, led by HBM Healthcare Investments. Other investors included LYZZ Capital, which previously led a Series A funding round for the company. Neurelis will use the funds to complete clinical trials for its intranasal diazepam spray and prepare a new drug application to submit to the FDA.
The round, which closed at an undisclosed amount, comes just 1 day after the company said that the FDA granted fast track designation for its diazepam spray, NRL-1. The intranasal formulation is being developed for pediatric and adult epilepsy patients with acute repetitive or...
Source: Mass Device - January 5, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Funding Roundup Neurological Pharmaceuticals Neurelis Inc. Source Type: news
Neurelis wins fast track designation from FDA for intranasal diazepam spray
Neurelis, Inc. said today that it won fast track designation from the FDA for its intranasal diazepam spray. The nasal formulation of diazepam, which is being developed for pediatric and adult epilepsy patients who experience repititive or cluster seizures, is in the final stage of clinical development, according to Neurelis. The company expects to submit a new drug application to the federal watchdog by early 2018.
“We are very excited to have received fast track designation status with the FDA,” president & CEO Craig Chambliss said in prepared remarks. “We are looking forward to working with the...
Source: Mass Device - January 4, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Neurological Pharmaceuticals Regulatory/Clearance Wall Street Beat Neurelis Inc. Source Type: news
Diazepam (Diazepam Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 4, 2017 Category: Drugs & Pharmacology Source Type: news
